NASDAQ:LFVN - LifeVantage Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $15.88 +0.20 (+1.28 %) (As of 02/15/2019 04:00 PM ET)Previous Close$15.88Today's Range$15.51 - $15.9852-Week Range$3.20 - $17.08Volume100,089 shsAverage Volume192,132 shsMarket Capitalization$226.77 millionP/E Ratio31.14Dividend YieldN/ABeta0.8 ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs. It also provides skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, and micro-lift serums; and Hair Care System under the TrueScience brand name. The company sells its products through a direct sales model, as well as a network of independent distributors in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands, Germany, and Taiwan. LifeVantage Corporation is headquartered in Sandy, Utah. Receive LFVN News and Ratings via Email Sign-up to receive the latest news and ratings for LFVN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:LFVN Previous Symbol CUSIPN/A Webwww.lifevantage.com Phone801-432-9000Debt Debt-to-Equity Ratio0.12 Current Ratio1.52 Quick Ratio1.06Price-To-Earnings Trailing P/E Ratio31.14 Forward P/E Ratio32.41 P/E GrowthN/A Sales & Book Value Annual Sales$203.20 million Price / Sales1.12 Cash Flow$0.6227 per share Price / Cash Flow25.50 Book Value$1.47 per share Price / Book10.80Profitability EPS (Most Recent Fiscal Year)$0.51 Net Income$5.76 million Net Margins2.92% Return on Equity35.08% Return on Assets14.46%Miscellaneous Employees109 Outstanding Shares14,280,000Market Cap$226.77 million OptionableOptionable LifeVantage (NASDAQ:LFVN) Frequently Asked Questions What is LifeVantage's stock symbol? LifeVantage trades on the NASDAQ under the ticker symbol "LFVN." How will LifeVantage's stock buyback program work? LifeVantage announced that its Board of Directors has approved a stock buyback plan on Tuesday, November 28th 2017, which authorizes the company to repurchase $5,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued. How were LifeVantage's earnings last quarter? LifeVantage Corp (NASDAQ:LFVN) announced its quarterly earnings results on Monday, February, 4th. The company reported $0.13 earnings per share (EPS) for the quarter. The firm earned $58.17 million during the quarter. LifeVantage had a net margin of 2.92% and a return on equity of 35.08%. View LifeVantage's Earnings History. When is LifeVantage's next earnings date? LifeVantage is scheduled to release their next quarterly earnings announcement on Wednesday, May 8th 2019. View Earnings Estimates for LifeVantage. What guidance has LifeVantage issued on next quarter's earnings? LifeVantage issued an update on its FY 2019 earnings guidance on Monday, February, 4th. The company provided earnings per share guidance of $0.46-0.52 for the period. The company issued revenue guidance of $222-232 million. Has LifeVantage been receiving favorable news coverage? News headlines about LFVN stock have been trending neutral recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. LifeVantage earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. Who are some of LifeVantage's key competitors? Some companies that are related to LifeVantage include Advanz Pharma (CXRXF), Retrophin (RTRX), Homology Medicines (FIXX), CannTrust (CNTTF), Athenex (ATNX), ImmunoGen (IMGN), CytomX Therapeutics (CTMX), Radius Health (RDUS), Apellis Pharmaceuticals (APLS), G1 Therapeutics (GTHX), Arvinas (ARVN), Intra-Cellular Therapies (ITCI), Y-mAbs Therapeutics (YMAB), Inflarx (IFRX) and Evolus (EOLS). Who are LifeVantage's key executives? LifeVantage's management team includes the folowing people: Mr. Darren Jay Jensen, Pres, CEO & Director (Age 50)Mr. Steven R. Fife, Chief Financial Officer (Age 58)Mr. Charles J. Wach, Chief Operating Officer (Age 57)Mr. Kevin McMurray, Gen. CounselMr. Ryan Goodwin, Chief Marketing Officer (Age 42) Who are LifeVantage's major shareholders? LifeVantage's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Acadian Asset Management LLC (2.04%), Dimensional Fund Advisors LP (2.02%), BlackRock Inc. (1.70%), Geode Capital Management LLC (0.72%), Algert Global LLC (0.56%) and Barclays PLC (0.43%). Company insiders that own LifeVantage stock include Darren Jay Jensen, Garry Paul Mauro and Raymond B Greer. View Institutional Ownership Trends for LifeVantage. Which institutional investors are selling LifeVantage stock? LFVN stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Investments LP, Algert Global LLC, Northern Trust Corp and Acadian Asset Management LLC. View Insider Buying and Selling for LifeVantage. Which institutional investors are buying LifeVantage stock? LFVN stock was bought by a variety of institutional investors in the last quarter, including Barclays PLC, Alambic Investment Management L.P., Dimensional Fund Advisors LP, GSA Capital Partners LLP, Squarepoint Ops LLC, Raymond James & Associates, O Shaughnessy Asset Management LLC and Geode Capital Management LLC. Company insiders that have bought LifeVantage stock in the last two years include Darren Jay Jensen, Garry Paul Mauro and Raymond B Greer. View Insider Buying and Selling for LifeVantage. How do I buy shares of LifeVantage? Shares of LFVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is LifeVantage's stock price today? One share of LFVN stock can currently be purchased for approximately $15.88. How big of a company is LifeVantage? LifeVantage has a market capitalization of $226.77 million and generates $203.20 million in revenue each year. The company earns $5.76 million in net income (profit) each year or $0.51 on an earnings per share basis. LifeVantage employs 109 workers across the globe. What is LifeVantage's official website? The official website for LifeVantage is http://www.lifevantage.com. How can I contact LifeVantage? LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 300, SANDY UT, 84070. The company can be reached via phone at 801-432-9000 or via email at [email protected] MarketBeat Community Rating for LifeVantage (NASDAQ LFVN)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 92 (Vote Outperform)Underperform Votes: 84 (Vote Underperform)Total Votes: 176MarketBeat's community ratings are surveys of what our community members think about LifeVantage and other stocks. Vote "Outperform" if you believe LFVN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LFVN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/16/2019 by MarketBeat.com StaffFeatured Article: How is the discount rate different from the Federal Funds rate?